Filter Results:
(296)
Show Results For
- All HBS Web
(296)
- People (1)
- News (83)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
Show Results For
- All HBS Web
(296)
- People (1)
- News (83)
- Research (187)
- Multimedia (4)
- Faculty Publications (124)
Page 1 of 296
Results →
- Article
Genetic Optimization of Photonic Bandgap Structures
By: Joel Goh, Ilya Fushman, Dirk Englund and Jelena Vuckovic
Goh, Joel, Ilya Fushman, Dirk Englund, and Jelena Vuckovic. "Genetic Optimization of Photonic Bandgap Structures." Optics Express 15, no. 13 (June 25, 2007): 8218–8230.
- March 1997 (Revised July 1997)
- Case
Genzyme Genetics
Rosenbloom, Richard S., and Ellen Pruyne. "Genzyme Genetics." Harvard Business School Case 797-073, March 1997. (Revised July 1997.)
- April 1987 (Revised May 1990)
- Case
Molecular Genetics
Rukstad, Michael G. "Molecular Genetics." Harvard Business School Case 387-167, April 1987. (Revised May 1990.)
- February 1987 (Revised March 1987)
- Case
Genetics Institute, Inc.
Rhea, James T. "Genetics Institute, Inc." Harvard Business School Case 187-104, February 1987. (Revised March 1987.)
- April 1985 (Revised August 1989)
- Case
Integrated Genetics (D)
Kao, John J. "Integrated Genetics (D)." Harvard Business School Case 485-155, April 1985. (Revised August 1989.)
- November 1983 (Revised November 1986)
- Case
Integrated Genetics (B)
Kao, John J. "Integrated Genetics (B)." Harvard Business School Case 484-046, November 1983. (Revised November 1986.)
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details
Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- November 1999
- Article
Understanding the Code: State Genetic Information Laws
This paper is a comprehensive survey of U.S. state genetic information privacy laws. View Details
- November 1983 (Revised November 1987)
- Case
Integrated Genetics (A)
Kao, John J. "Integrated Genetics (A)." Harvard Business School Case 484-045, November 1983. (Revised November 1987.)
- November 2009
- Case
The Explosion of Genetic Testing: Opportunities and Challenges
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay... View Details
- June 1992
- Teaching Note
Genetics Institute, Inc., Teaching Note
By: Regina E. Herzlinger and James T. Rhea
Keywords: Genetics
- June 2017
- Supplement
23andMe: Genetic Testing for Consumers (C)
By: John A. Quelch, Irene Lu and Emily Boudreau
Quelch, John A., Irene Lu, and Emily Boudreau. "23andMe: Genetic Testing for Consumers (C)." Harvard Business School Supplement 517-129, June 2017.
- October 2001 (Revised June 2002)
- Case
Centagenetix (A): Building a Business Model for Genetic Longevity
Describes a start-up company seeking to exploit population genetic data from long-lived, healthy people. The company must address legal, financial, ethical, and personal issues among its team to launch the company. View Details
Chesbrough, Henry W., and Frank Angella. "Centagenetix (A): Building a Business Model for Genetic Longevity." Harvard Business School Case 602-087, October 2001. (Revised June 2002.)
- January 2014 (Revised June 2014)
- Supplement
23andMe: Genetic Testing for Consumers (B)
By: John A. Quelch and Margaret L. Rodriguez
Following the FDA's letter in November 2013, which ordered 23andMe to cease sales of its DNA test kits, observers wondered how co-founder and CEO, Anne Wojcicki, would guide the company in the presence of uncertainty. View Details
Keywords: Risk and Uncertainty; Genetics; Crisis Management; Health Care and Treatment; Product Development; Business and Government Relations; Biotechnology Industry; Consumer Products Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (B)." Harvard Business School Supplement 514-095, January 2014. (Revised June 2014.)
- October 2009 (Revised November 2016)
- Case
Generation Health: A Pioneer in Genetics Benefit Management (A)
By: Robert F. Higgins, Jeffrey D. Marrazzo and Rachel Gordon
Generation Health, a pioneer in the new field of genetics benefit management and a newly formed company, faces many strategic issues. CEO Per Lofberg is in the midst of negotiating a partnership with a major pharmacy benefit management company. As part of these... View Details
Keywords: Business Startups; Entrepreneurship; Governing Rules, Regulations, and Reforms; Growth and Development Strategy; Partners and Partnerships; Genetics; Health Industry; Insurance Industry
Higgins, Robert F., Jeffrey D. Marrazzo, and Rachel Gordon. "Generation Health: A Pioneer in Genetics Benefit Management (A)." Harvard Business School Case 810-007, October 2009. (Revised November 2016.)
- November 1985
- Case
Genetics Institute Enters the Seed Business
By: Ray A. Goldberg and Michael Joseph Kennedy
Goldberg, Ray A., and Michael Joseph Kennedy. "Genetics Institute Enters the Seed Business." Harvard Business School Case 586-077, November 1985.
- March 2014 (Revised April 2014)
- Teaching Note
23andMe: Genetic Testing for Consumers (A) and (B)
By: John A. Quelch
- May 2009 (Revised August 2013)
- Case
The DiagnoFirst Opportunity
By: Robert C. Pozen and Rukmini Balu
John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a genetic test that identified a subset of prostate cancer patients with a high risk of clinical... View Details
Keywords: Genetic Engineering; Genetically Modified; Genomics; Venture Capital; Patents; Genetics; Decision Choices and Conditions; Laws and Statutes; Investment; Science-Based Business; Biotechnology Industry
Pozen, Robert C., and Rukmini Balu. "The DiagnoFirst Opportunity." Harvard Business School Case 309-112, May 2009. (Revised August 2013.)
- December 1998 (Revised April 1999)
- Case
Mind of the Market: Genetics and Behavior, Primer Five
By: Gerald Zaltman and Kathryn A. Braun
Zaltman, Gerald, and Kathryn A. Braun. "Mind of the Market: Genetics and Behavior, Primer Five." Harvard Business School Case 599-005, December 1998. (Revised April 1999.)
- August 2013
- Article
Lords of the Harvest: Third-party Influence and Regulatory Approval of Genetically Modified Organisms
By: Shon R. Hiatt and Sangchan Park
Little is known about the factors that influence regulatory-agency decision making. We posit that regulatory agencies are influenced by the firms they regulate, but not exclusively via dyadic exchanges as is traditionally argued in the regulatory capture and... View Details
Hiatt, Shon R., and Sangchan Park. "Lords of the Harvest: Third-party Influence and Regulatory Approval of Genetically Modified Organisms." Academy of Management Journal 56, no. 4 (August 2013): 923–944.